DJ-1: A Potential Biomarker Related to Prognosis, Chemoresistance, and Expression of Microenvironmental Chemokine in HR-Positive Breast Cancer

Figure 6

The sensitivity in immunotherapy and chemotherapy. The sensitivity in immunotherapy and chemotherapy between the high and low DJ-1 expression groups: (a) the chemosensitivity to paclitaxel, docetaxel, and doxorubicin was found different between high and low DJ-1 expression groups; (b) higher TMB was related with high level of DJ-1; (c) CTLA-4 and PD-L1 showed higher sensitivity in the high-DJ-1 expression group. IC₅₀: half maximal inhibitory concentration.

(a)

(b)

(c)